Junshi steps up efforts in Europe by filing for the NDA of toripalimab Nov. 16, 2022 By Doris Yu No Comments Shanghai Junshi Biosciences Co. Ltd. has submitted a new drug application (NDA) for its anti-PD-1 monoclonal antibody toripalimab to the European Medicines Agency, which marks the first NDA filing of toripalimab in Europe.Read More